139 related articles for article (PubMed ID: 9148412)
21. Decreased immunologic responsiveness following intensified vaginal immunization against urinary tract infection.
Uehling DT; Hopkins WJ; Balish E
J Urol; 1990 Jan; 143(1):143-5. PubMed ID: 2403596
[TBL] [Abstract][Full Text] [Related]
22. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
23. Immunization against urinary tract infection with a multi-valent vaginal vaccine.
Uehling DT; James LJ; Hopkins WJ; Balish E
J Urol; 1991 Jul; 146(1):223-6. PubMed ID: 2056594
[TBL] [Abstract][Full Text] [Related]
24. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
[TBL] [Abstract][Full Text] [Related]
25. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
Svennerholm AM; Holmgren J
Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
[No Abstract] [Full Text] [Related]
26. Local and systemic antibody response in infants after oral administration of inactivated enteropathogenic E. coli serotype O111 and O55.
Lodinová-Zádníková R; Korych B; Gajdostíková K
Folia Microbiol (Praha); 1990; 35(2):155-62. PubMed ID: 1696237
[TBL] [Abstract][Full Text] [Related]
27. [Urinary tract infections, immunity, and vaccination].
Luna-Pineda VM; Ochoa S; Cruz-Córdova A; Cázares-Domínguez V; Vélez-González F; Hernández-Castro R; Xicohtencatl-Cortes J
Bol Med Hosp Infant Mex; 2018; 75(2):67-78. PubMed ID: 29658949
[TBL] [Abstract][Full Text] [Related]
28. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
[TBL] [Abstract][Full Text] [Related]
29. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis.
Li X; Erbe JL; Lockatell CV; Johnson DE; Jobling MG; Holmes RK; Mobley HL
Infect Immun; 2004 Dec; 72(12):7306-10. PubMed ID: 15557656
[TBL] [Abstract][Full Text] [Related]
30. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
Schilling JD; Mulvey MA; Hultgren SJ
J Infect Dis; 2001 Mar; 183 Suppl 1():S36-40. PubMed ID: 11171011
[No Abstract] [Full Text] [Related]
32. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice.
Bouzari S; Dashti A; Jafari A; Oloomi M
Comp Immunol Microbiol Infect Dis; 2010 May; 33(3):215-25. PubMed ID: 19022502
[TBL] [Abstract][Full Text] [Related]
33. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
34. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.
O'Hagan DT
Clin Pharmacokinet; 1992 Jan; 22(1):1-10. PubMed ID: 1559304
[No Abstract] [Full Text] [Related]
35. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
36. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
[TBL] [Abstract][Full Text] [Related]
37. Modern vaccines. Pneumococcus and influenza.
Shann F
Lancet; 1990 Apr; 335(8694):898-901. PubMed ID: 1969994
[No Abstract] [Full Text] [Related]
38. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
39. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
[TBL] [Abstract][Full Text] [Related]
40. Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect.
Wasserman SS; Kotloff KL; Losonsky GA; Levine MM
Am J Epidemiol; 1993 Dec; 138(11):988-93. PubMed ID: 8256784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
